Business
New virtual study with COVID-19 healthcare workers
New virtual study with COVID-19 healthcare workers.
About this update from Cambridge Cognition Holdings Plc
[{"type":"text","content":"\n \n \n RNS Number : 0097T\n Cambridge Cognition Holdings PLC\n 15 July 2020\n \n \n \n \n \n \n \n Cambridge Cognition Holdings Plc\n \n \n \n (\"\n \n \n Cambridge Cognition\"\n \n \n \n \n \n or the \"Company\")\n \n \n \n \n \n \n New virtual study with COVID-19 healthcare workers\n \n \n \n \n \n New virtual study to measure stress recovery in frontline health workers caring for COVID-19 patients \n \n \n \n \n \n Cambridge Cognition Holdings plc (AIM: COG), which develops and markets digital solutions to assess brain health, is collaborating with 4YouandMe and The Center for International Emergency Medical Services (\"CIEMS\") to investigate the utility of wearables and mobile phones to measure stress recovery in frontline healthcare workers in the USA caring for COVID-19 positive patients. This virtual study will take place over 6-12 months with up to 500 participants. The project is charity funded and Cambridge Cognition are supporting the project by providing the digital cognitive assessments.\n \n \n \n \n \n Many healthcare workers worldwide are experiencing high levels of stress as they work on the frontline caring for COVID-19 positive patients. Stress negatively affects the immune system1, which in turn can increase susceptibility to infection. Accurate measurement of stress responses in real-time will be key to better understanding whether stress is a significant risk factor for frontline healthcare workers contracting COVID-19. \n \n \n \n \n \n Carrying a mobile phone or wearable is now a habit for most, so the devices are ideally suited to capture subtle fluctuations in wellbeing. The primary goal of the project is to determine whether mobile phones and wearables are a feasible means of detecting and tracking real-time changes in stress and recovery as frontline healthcare workers transition between \"on-shift\" and \"off-shift\" with COVID-19 patients. The secondary goal is to determine whether these digital signals can inform risk-detection for COVID-19 infectivity. \n \n \n \n \n \n Cambridge Cognition is the cognitive assessment partner for this exploratory research project: supporting the identification of clinically meaningful signs of stress, such as mood shifts and changes in cognitive performance. \n \n \n \n \n \n Matthew Stork, Chief ...